In August 2017, Maureen Hanson participated in the Stanford Chronic Fatigue Syndrome Research Center Collaborative Team Meeting on the Molecular Basis of ME/CFS.
In June 2017, Prof. Maureen Hanson and Research Associate Ludovic Giloteaux participated in the InvestinME Research Colloquium in London, England.
Collaboration between Weill Cornell Medicine and Mount Sinai Beth Israel published in the April issue of the Journal of Neurological Sciences
A review article about the Gut Microbiome in ME/CFS by Maureen Hanson and Ludovic Giloteaux is freely available in the April 2017 issue of The Biochemist Magazine:
Advances in Metabolic Research provide new perspectives on Bioenergetics and Energy Metabolism
Brian Dranka, Ph.D.
Director of Biology and Applications, Agilent Technologies
Friday, December 6, 2016
9:00 AM, Room G01 Biotechnology Building
Cornell University, Ithaca, NY
Physiological responses to exertion are abnormal and unique in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Betsy Keller, Ph.D. Professor
School of Health Sciences and Human Performance, Ithaca College
Monday, November 21, 2016 4:00 PM Room G01 Biotechnology Building
Cornell University, Ithaca, NY
Understanding Myalgic Encephalomyelitis and Chronic Fatigue Syndrome disease in the US caused by chronically disabling enterovirus
Byron Hyde, M.D.
Nightingale Research Foundation
Friday, November 18, 2:00 PM
Room G01 Biotechnology Building
A number of Members of the Cornell ENID Center will present research at the IACFS/ME meeting in October in Fort Lauderdale, Florida.
The patient agenda also includes Daniel Peterson, M.D. on a panel discussion on Rituximab and Emerging Treatments.
The following presentations by Cornell ENID Center members are in the Professional Agenda:
Workshop: How cardiopulmonary exercise testing informs pathology and treatment
Mark VanNess, Ph.D., Christopher Snell, PhD (Workwell Foundation), Betsy Keller, Ph.D. (Ithaca College)
Workshop: Acute and chronic enteroviral infection
John Chia, M.D. (UCLA School of Medicine)
How cardiopulmonary exercise testing informs pathology and treatment
Betsy Keller, Ph.D. (Ithaca College)
Alterations in the enteric bacterial and viral microbiome in ME/CFS
Ludovic Giloteaux, Ph.D. (Cornell University)
N-Acetylcysteine alleviates cortical glutathione deficit and improves symptoms in CFS:
An in vivo validation study using proton magnetic resonance spectroscopy
Dikoma Shungu, Ph.D. (Weill Cornell Medicine)
Mitochondrial dysfunction: A potential etiology for ME/CFS?
Panelist Dikoma Shungu, Ph.D., (Weill Cornell Medicine)
Diagnosing CFS/ME; Difficult clinical cases: focus on fatigue and pain
John Chia, M.D. (UCLA School of Medicine), Dan Peterson, M.D., Sierra Internal Medicine, Nevada
Allergic disorder phenotypes in ME/CFS and patterns of medical comorbidity and clinical dysfunction
Susan Levine, M.D Private Practice, Manhattan, NY and Cornell University
Cardiopulmonary exercise testing demonstrates post-exertional chronotropic incompetence
Mark Van Ness, Ph.D. (Workwell Foundation)
Subsets of ME/CFS patient responses to a 2-day CPET
Betsy Keller, Ph.D., Ithaca College
Polar metabolites distinguish ME/CFS patients and controls
Maureen Hanson, Ph.D., Cornell University
Fellowship opportunity in ME/CFS
Daniel Peterson, M.D., Simmaron Research
Assessment of Neurobiological Dysfunction in Chronic Fatigue Syndrome
Benjamin H. Natelson, Xiangling Mao, Diana Vu, Michelle Blate, Gudrun Lange, Aaron J Stegner, Guoxin Kang and Dikoma C. Shungu
Poster: Chronic fatigue syndrome (CFS): a presumptive mitochondrial disorder
L Bulone, AE Slonim, C Warshafs, M Grovit, T Goldberg, J Chouinard, DC Shungu
Poster: Eukaryotes in the ME/CFS gut microbiome
Alexandra Mandarano, Ph.D. student
A devastating illness that needs a better name
Garnet News October 19, 2016
Chronic Fatigue Syndrome is an illness that many may have heard of, but few, in reality, know much about.
The misconception of the seriousness of the disease is in part caused by the use of the name Chronic Fatigue Syndrome (CFS), coined in 1988 by a committee convened at the Centers for Disease Control. Prior to that recommendation, the disease was known by the more intimidating name Myalgic Encephalomyelitis (ME), which is favored by many patients and still used in many countries overseas. Chronic Fatigue Syndrome trivializes the nature of the disease and its impact on the lives of the people who suffer with it.